Physician profile
Melanie Friedlander
NPI 1770596330
$10,205.93
in general payments reported to CMS, 2019-2025
13 companies · $453 in 2025
The $453 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,630 · 2020: $199 · 2021: $850 · 2022: $2,829 · 2023: $764 · 2024: $480 · 2025: $453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,697.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,697.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,517.30 | 2019-2024 | Da Vinci Surgical System |
| Medtronic, INC. | $1,781.16 | 2021-2025 | Ligasure, Signia, Sonicision |
| Covidien LP | $1,726.75 | 2019-2020 | |
| Davol INC. | $291.37 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $210.73 | 2021-2025 | |
| Stryker Corporation | $147.40 | 2025 | Molli |
| Seagen INC. | $114.67 | 2022 | |
| Baxter Healthcare | $106.67 | 2019 | |
| Genzyme Corporation | $100.83 | 2023 | |
| Pfizer INC. | $98.65 | 2024 | |
| Teleflex LLC | $66.67 | 2019 | |
| Glaxosmithkline, LLC. | $27.67 | 2022 | |
| Myriad Genetic Laboratories, INC. | $16.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Friedlander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.